Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$6.93 USD
-0.29 (-4.02%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $6.93 0.00 (0.00%) 6:48 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Nu Skin Enterprises, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,969 | 2,226 | 2,696 | 2,582 | 2,420 |
Cost Of Goods | 612 | 631 | 675 | 658 | 581 |
Gross Profit | 1,357 | 1,595 | 2,020 | 1,924 | 1,839 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,309 | 1,484 | 1,786 | 1,666 | 1,572 |
Income After Depreciation & Amortization | 48 | 111 | 234 | 258 | 267 |
Non-Operating Income | -22 | -22 | -2 | -1 | -12 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 27 | 89 | 232 | 256 | 255 |
Income Taxes | 18 | -16 | 85 | 65 | 82 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 9 | 105 | 147 | 191 | 174 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 9 | 105 | 147 | 191 | 174 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 119 | 183 | 310 | 332 | 344 |
Depreciation & Amortization (Cash Flow) | 71 | 73 | 76 | 74 | 77 |
Income After Depreciation & Amortization | 48 | 111 | 234 | 258 | 267 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 49.86 | 50.53 | 51.43 | 52.77 | 55.93 |
Diluted EPS Before Non-Recurring Items | 1.85 | 2.90 | 4.14 | 3.63 | 3.10 |
Diluted Net EPS (GAAP) | 0.17 | 2.07 | 2.86 | 3.63 | 3.10 |
Fiscal Year end for Nu Skin Enterprises, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 439.08 | 417.31 | 488.64 | 498.77 | 500.26 |
Cost Of Goods | 131.90 | 123.24 | 136.22 | 206.51 | 135.54 |
Gross Profit | 307.18 | 294.06 | 352.43 | 292.27 | 364.72 |
SG&A, R&D, and Dept/Amort Expenses | 432.73 | 285.24 | 336.36 | 318.63 | 322.21 |
Income After SG&A, R&D, and Dept/Amort Expenses | -125.55 | 8.82 | 16.07 | -26.36 | 42.51 |
Non-Operating Income | 0.63 | -0.40 | -6.74 | -8.09 | -5.39 |
Interest Expense | 6.72 | 7.33 | 0.00 | 0.00 | 0.00 |
Pretax Income | -131.65 | 1.10 | 9.33 | -34.45 | 37.11 |
Income Taxes | -13.39 | 1.63 | 2.05 | 2.50 | 10.22 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -118.26 | -0.53 | 7.28 | -36.96 | 26.89 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -118.26 | -0.53 | 7.28 | -36.96 | 26.89 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 49.69 | 49.54 | 49.48 | 49.86 | 50.16 |
Diluted EPS Before Non-Recurring Items | 0.21 | 0.09 | 0.37 | 0.56 | 0.54 |
Diluted Net EPS (GAAP) | -2.38 | -0.01 | 0.14 | -0.74 | 0.54 |